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Abstract In order to study the transactivational property of the
X gene in the methylotropic yeast Pichia pastoris, a Rous
sarcoma virus-chloramphenicol acetyltransferase (RSV-CAT)
cassette was co-transformed and integrated into the host yeast
strain as a reporter which showed an overwhelming CAT activity.
Immunoprecipitation of the yeast cell extracts with an X-specific
monoclonal antibody, however, showed a low level expression of
the X gene. Therefore besides a trans-effect of the X protein, the
enhanced reporter activity could be a manifestation of a cis-effect
of the X gene sequences also. Therefore, unlike the transactiva-
tion studies with X gene in animal cells where limited functional
activity is observed, P. pastoris appears to be an excellent system
to study cis- and trans-aspects of gene regulation by the X gene.
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1. Introduction
The hepatitis B virus (HBV) is the infective agent for the
widespread liver disease in humans known as hepatitis B. The
small 3.2 kbp DNA genome of HBV has at least four open
reading frames called S, C, P and X. During the natural
course of HBV infection, the X gene expresses a polypeptide
(HBx) of 154 residues that is implicated in HBV-mediated
hepatocellular carcinoma [1,2].
The X gene is the smallest of four open reading frames and
is expressed during the natural course of HBV infection [3].
Under certain conditions, the X gene product or HBx can
have oncogenic potential that may be relevant for HBV-asso-
ciated liver carcinogenesis [4], but until now the mechanism
for cell transformation by HBx has been unclear. Investiga-
tions suggest that HBx is a pleiotropic transactivator (for re-
views [5,6]). The pleiotropic nature of HBx may be attributed
to the diverse properties associated with it. It displays ATPase
and protein kinase-like activities, interacts with a number of
host-cell factors, and more importantly can modulate cellular
signal-transduction pathways. HBx is a transcriptional activa-
tor of not only the HBV genome but also a wide range of
other viral and cellular promoters. It is known to activate
target genes that incorporate cis-elements for some common
trans-factors like AP-1, AP-2, C/EBP and NFUB. However,
there is no evidence for a direct interaction between HBx and
these transcription factors. Characterisation of protein do-
mains that are important for its various activities have al-
lowed identi¢cation of at least two regions of HBx that are
essential for its transactivation function [7]. Extensive muta-
tional analysis has shown that other regions in the molecule
were dispensable for this function. The ability of X5 to trans-
activate the RSV-LTR was similar to the wild-type values.
Our desire to express a transactivation competent mutant of
X in yeast was further enhanced by the fact that this protein
expressed in Escherichia coli was biologically inactive and
showed minimal functional activity in animal cells [7] render-
ing further usage very di⁄cult. Pichia pastoris on the other
hand has been an excellent system for expressing biologically
functional heterologous proteins in a soluble form.
P. pastoris has proved to be superior to S. cerevisiae for the
expression of certain proteins [8,9] and has now been devel-
oped as an e⁄cient host for heterologous gene expression
using the promoter from the gene coding for alcohol oxidase
(AOX1) [10,11]. Alcohol oxidase is the ¢rst enzyme in the
methanol utilisation pathway and is induced by methanol
[12] and constitutes about 20^30% of total cellular protein
in methanol-grown cells. Regulation of heterologous gene ex-
pression by methanol has been shown to be simple, easy to
scale up and cost-e¡ective for industrial fermentation [9]. The
functional components of the P. pastoris yeast expression sys-
tem are the transfer vector and the host. The his3 host strain
can metabolise methanol as its sole carbon source by the
action of the AOX1 gene product. The promoter for this
gene induces a high level of tightly controlled gene expression.
Recombination of the transfer vector into the yeast genome
provides for auxotrophic selection by providing the ability of
the transformed yeast to grow on plates lacking histidine. The
vector is biodesigned to replace the structural component of
the AOX1 gene with the recombinant gene of interest upon
recombination with the yeast genome. Proper recombination
of the transfer vector results in a his and mut3 (lacking the
ability to utilise methanol e⁄ciently) phenotype. Providing the
recombinants with methanol as a sole carbon source induces
expression of the recombinant protein.
In this study, we report the expression of a transactivation
competent mutant (X5) of X gene of HBV in P. pastoris. An
RSV-CAT cassette was co-transformed and integrated into
the yeast P. pastoris as a reporter for transactivation by X.
The expressed X protein in P. pastoris is highly bioactive since
overwhelming CAT activity can be seen compared to the cor-
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responding untransformed host or host with either the RSV-
CAT cassette or X alone.
2. Materials and methods
2.1. Culture media
MD (minimal dextrose) medium is 1.34% yeast nitrogen base
(YNB), 1% dextrose, and 4U1035% biotin. MM (minimal methanol)
medium is 1.34% YNB, 0.5% methanol, and 4U1035% biotin. YPD
and E. coli culture media were prepared using standard protocols.
2.2. Host strains and recombinant plasmids
The P. pastoris strain GS115 (his43), a derivative of NRRLY-11430
(SC-5) that has been previously described [12] was used in all yeast
experiments. The P. pastoris expression plasmid used for all the con-
structs was pAO815 [13] (8.12 kbp) commercially available from In-
vitrogen, Carlsbad, CA, USA. The three plasmid constructs used in
this work were pAO815-X-CAT (13.12 kbp), pAO815-X (8.12 kbp)
and pAO815-CAT (12.71) as shown in Fig. 1 (A, B and C respec-
tively). The X5 gene open reading frame [7] was cloned at the EcoRI
site, to create pAO815-X. The unique BamHI site in the original
plasmid was used to insert the RSV-CAT reporter cassette [14] to
create pAO815-CAT. pAO815-X-CAT was constructed by cloning
the RSV-CAT cassette at the BamHI site of pAO815-X5.
2.3. Transformation, screening and selection of expressing
transformants
Vectors pAO815-X-CAT, pAO815-CAT and pAO815-X were di-
gested with BglII prior to transformation, generating a fragment ca-
pable of displacing the chromosomal AOX1 gene by double crossover
recombination (transplacement) [15]. P. pastoris host GS115 (his43)
was transformed using the LiCl method as described before [11].
Transformants were visible after 3^4 days. These AOX13 trans-
formants had the muts phenotype that showed slow growth on min-
imal media containing methanol as the sole carbon and energy source
due to replacement of the AOX1 structural gene with the foreign gene.
The reason AOX1 transformants grow at all on methanol is due to
low-level expression of a second functional alcohol oxidase (AOX2)-
encoding gene [15]. In initial screening, the His4 gene was used as a
selectable marker, with about 20% of the transformants showing the
muts phenotype.
Twenty ¢ve muts transformants were grown in a 5 ml glucose me-
dium for 48 h after which they were switched to the methanol induc-
tion medium as described previously [11]. The cells were harvested by
centrifugation at 3000 rpm for 5 min and suspended in alkaline lysis
bu¡er pH 10.5 containing 50 mM NaOH/2 mM EDTA/1 mM PMSF/
2% SDS/10% glycerol. The suspension was boiled for 5 min and
adjusted to pH 7.5 with 1 M HCl. Total cellular protein samples
were electrophoresed in a 15% polyacrylamide gel with SDS as de-
scribed previously [11]. Expressing clones were selected by Western
blot analysis (Fig. 1D) using the primary antibody against HBx as
described previously [7].
2.4. CAT assay
Functional analysis of X5 was performed on RSV-CAT in induced
cell lysates from transformants and appropriate control cells. CAT
activity was measured as described [14]. Quantitative assay was per-
formed by measuring the radioactivity of the substrate and product
spots using liquid scintillation counting.
3. Results
3.1. Expression of X
To express X in P. pastoris we used the vectors pAO815-X
and pAO815-X-CAT. The X gene [5] was inserted between the
Fig. 1. Pichia pastoris expression constructs. Three expression constructs containing both the X gene and the RSV-CAT expression cassette (A)
or the X gene alone (B) or the RSV-CAT expression cassette alone (C) were made using the pAO815 vector. All constructs contain genes for
his4 selection, ampicillin resistance (Amp), 5P and 3P alcohol oxidase 1 (AOX1) regions for integration into the AOX1 locus of the genome. D
shows the Western blot analysis of the expressed HBx protein in transformants obtained by vectors pAO815-X-CAT and pAO815-X. GS115 is
the untransformed host. The E. coli expressed X protein (16 kDa) was used as a size marker and a positive control on the Western blot. Pro-
tein HBx expressed in the P. pastoris transformants corresponds to 14 kDa since the insert was a transactivation competent mutant (X5) of X
gene of HBV.
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promoter and transcriptional terminator of the AOX1 gene.
Induced transformants were lysed after three days and ana-
lysed by Western blots. Levels of expression of X were low
but detectable on Western blots on pAO815-X and pAO815-
X-CAT transformants (Fig. 1D). None of the pAO815-CAT
transformants or untransformed host GS115 showed any
bands on the Western blot.
3.2. Transactivation of RSV-LTR by X
To gain insight into the transactivation aspects of X pro-
tein, we made a construct pAO815-X-CAT having the bacte-
rial chloramphenicol acetyltransferase (CAT) gene under the
control of RSV-LTR. This expression cassette was integrated
into the P. pastoris host strain. The strategy to study trans-
activation in P. pastoris was to trigger the RSV-LTR by X. As
can be seen in Fig. 2A, the expression of RSV-LTR was X-
dependent and that all the ¢ve clones selected for the insertion
of the RSV-CAT reporter, showed an overwhelming CAT
activity (Fig. 2A, lanes 5^14). Cells harbouring either X
gene (pAO815-X, Fig. 2A, lanes 1, 2) or RSV-CAT reporter
(pAO815-CAT, Fig. 2A, lanes 3, 4) showed no CAT activity.
The level of CAT activation by X was as high as 120-fold. For
the present set of experiments cells were routinely harvested
three days after induction. Further, the CAT activity in our
experiments in the presence of X protein, was speci¢c for the
RSV-CAT reporter as can be seen in Fig. 2B. X gene
(pAO815-X) was unable to induce any endogenous CAT ac-
tivity even after three days of induction (Fig. 2B, lanes 1^8).
Under identical experimental conditions however, pAO815-X-
CAT was able to induce an overwhelming CAT response
(lanes 9 and 10).
3.3. Speci¢c CAT activity as a function of protein
concentration
A CAT activation analysis as a function of the amount of
protein taken for the assay was performed. Results (Fig. 3)
showed that as little as 3 ng of the crude extracts were able to
show CAT activity (lane 4). The CAT activity increased with
increasing concentration of protein (lanes 5^9). A concomi-
tant increase in 1,3-diacetyl form of chloramphenicol is sug-
gestive of the presence of highly active form of CAT enzyme
in these extracts. It is also possible that more stable CAT
enzyme expressed in yeast is more stable under the present
experimental conditions.
4. Discussion
The data presented in this report suggest that biologically
active transactivation competent HBx can be expressed in P.
pastoris by utilising the AOX1 promoter based system. P.
Fig. 2. Functional analysis of X on RSV-CAT. All clones were ana-
lysed in duplicate. (A) Lanes 1 and 2 show CAT activity for a
transformant with X gene alone. Lanes 3 and 4 show CAT activity
for a transformant with the RSV-LTR CAT construct alone. Lanes
5^14 show CAT activity for ¢ve selected transformants with
pAO815-X-CAT. (B) Lanes 1 and 2 show CAT activity of an unin-
duced transformant with pAO815-X. Lanes 3^8 show the pAO815-
X transformant 1, 2 and 3 days post-induction. Lanes 9 and 10 are
a pAO815-X-CAT clone, 3 days post-induction.
Fig. 3. Speci¢city of the CAT activity. Lane one shows CAT activ-
ity for the untransformed host. Lane 2 shows the activity for a
transformant with CAT only. Samples 3^11 show a gradient of in-
creasing ng protein level (crude lysate) of the pAO815-X-CAT
transformant (clone #7). The three forms of acetylated chloramphe-
nicol are marked as 1-acetyl chloramphenicol (Cm), 3-acetyl Cm
and 1,3-diacetyl Cm.
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pastoris can grow on methanol as the sole carbon and energy
source as it contains a highly regulated methanol utilisation
pathway [16,17]. The AOX1 promoter is tightly regulated and
is used in this study to trigger HBx expression. HBx expressed
in P. pastoris is in the soluble form and can be readily ex-
tracted by mechanical shearing of cells under non-denaturing
conditions. Compared with expression in prokaryotes, yeast
expression has the advantage of providing eukaryotic post-
translational modi¢cations. Expression in P. pastoris thus
leads to a correctly folded highly bioactive product, as is the
case with HBx. This transactivator protein has shown, in P.
pastoris to be of great potential by the fact that it shows an
overwhelming CAT response. This suggests that the yeast in-
tracellular environment is more conducive to the folding/sec-
ondary modi¢cations of HBx into its native state.
No di¡erence in the levels of transactivation of RSV-LTR
has been found when the wild-type X protein or its mutant X
were transfected separately in HepG2 cells [7]. Since the N-
terminal deletion (X5) in the X gene had no bearing on its
transactivation function, we used this X recombinant in the
present studies. We observed that the RSV-LTR could be
stimulated to a highly signi¢cant level (up to 120-fold) by
HBx. Under identical experimental conditions however, no
stimulation of the reporter was observed in the absence of
X suggesting the speci¢city of transactivation. As no back-
ground CAT activity was seen in the control samples. This
suggested that none of the endogenous P. pastoris transcrip-
tion factors were able to stimulate a heterologous viral pro-
moter like RSV-LTR.
SDS-PAGE analysis of the yeast cell extracts from the X-
harbouring cells apparently did not show induction of any
endogenous genes (data not shown). This suggests that X
protein may not be functioning as a universal transactivator
in P. pastoris. Further, no increase in endogenous CAT-like
activity was seen in yeast cells having X gene. Western blot
analysis revealed that X protein could be expressed to a very
low level in P. pastoris. Though this observation speaks in
favour of a highly bioactive X protein, a ‘cis’-e¡ect of the
X-encoding sequence on the RSV-LTR can not be ruled
out. It may be pertinent to mention here that the X-encoding
region of the HBV genome also encompasses a strong en-
hancer element (Enhancer II) and promoter elements for nu-
cleocapsid gene [18]. Thus, besides a trans-e¡ect of the X
protein on RSV-LTR, the core promoter and enhancer ele-
ments of HBV may be functional in P. pastoris. Transcription
factors bound to these regulatory elements could exert a pro-
found e¡ect on the RSV-LTR leading to a signi¢cant increase
in the reporter activity. It would be interesting to investigate
further whether the increased CAT activity in P. pastoris is a
manifestation of a ‘trans’- or ‘cis’-e¡ect of the X gene or is a
combined e¡ect of the two. In either case, it would be inter-
esting to work out the molecular mechanism of transactiva-
tion from the RSV-LTR in yeast cells. Initiation of eukaryotic
transcription by polymerase II depends on a set of general
transcription factors. These include TFIIA, TFIIB, TFIID,
TFIIE, TFIIF and TFIIH group of proteins. Initiation of
transcription requires assembly of general transcription fac-
tors and RNA polymerase II on the DNA template to form
a preinitiation complex [19]. Activation of transcription in-
volves interaction of other transactivators with this preinitia-
tion complex which could be involved in protein-DNA or
protein-protein interaction. Recent reports suggest that HBx
can directly interact with some of these general transcription
factors, like TFIIB, TFIID and TFIIH [20^22]. These factors
are reported to be present in yeast.
From the present study, we have been able to show a very
high level of HBx-mediated transactivation. It would be inter-
esting to investigate the molecular mechanism of interaction
of these general factors with HBx in P. pastoris.
HBx alone is able to transactivate the RSV-LTR in yeast.
This implies that (a) recruitment of the transcription process
can take place on the regulatory sequences of a mammalian
virus and (b) the viral X protein is able to interact with yeast
transcription factor/factors in the transcription initiation com-
plex and activate the process of transcription.
In fact in the recent past, a number of yeast proteins (XAP1
[23], XAP3 [24], XAPC7 [25], XIP [26], UVDDV [27] and
p55sen [28] have been cloned using the yeast two-hybrid system.
These proteins show very diverse functions suggesting the
promiscuous nature of HBx. The most alarming of all is
UVDDV since it is considered important in the repair process
of damaged DNA. HBx may be interacting with such proteins
in its natural host and may in£uence the DNA repair process
and transcription. It would be interesting to investigate if one
of these or a new yeast protein mediates the X-dependent
transactivation of RSV-LTR in P. pastoris. It is unlikely
that an X-like factor may exist in yeast, because the X-respon-
sive promoters, RSV-LTR, do not show any background re-
porter activity when P. pastoris is grown on methanol.
In this study a viral factor (HBx) is activating a viral LTR
in a lower eukaryote like yeast. For the ¢rst time, a viral gene
has been expressed to study viral gene regulation in a meth-
ylotrophic yeast expression system.
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